Vaginal Isonicotinic Acid Hydrazide Administration Prior to Intrauterine Device Insertion

• Status: Completed
• Trial end date: 2021-08-30
• Target enrollment: 0
• Participant gender: Female

Summary

To investigate whether vaginal isonicotinic acid hydrazide administered before the levonorgestrel-releasing intrauterine system insertion reduces IUD insertion pain and difficulty in insertion in adolescents and young women.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aswan University Hospital

Criteria

Inclusion Criteria:

• nulliparous adolescent and young women requesting levonorgestrel-releasing intrauterine device

Exclusion Criteria:

• pregnancy and

• contraindication or allergy to or contraindication to IUD insertion,

• chronic pelvic pain,

• pelvic inflammatory disease,

• analgesic intake 24 hours prior to IUD insertion.